Filing Details

Accession Number:
0001455244-10-000099
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-26 13:00:00
Reporting Period:
2010-04-22
Filing Date:
2010-04-26
Accepted Time:
2010-04-26 17:22:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
919722 Supergen Inc SUPG Pharmaceutical Preparations (2834) 911841574
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1360509 Florian Schonharting Oestergade 5, 3Rd Floor
Dk-1100
Copenhagen K G7
No No Yes No
1360573 Christian Hansen Oestergade 5, 3Rd Floor
Dk-1100
Copenhagen K G7
No No Yes No
1451330 K/S Equity Public Nb Oestergade 5, 3Rd Floor
Dk-1100
Copenhagen K G7
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Disposition 2010-04-22 26,768 $3.15 6,662,954 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 3,350 $3.16 6,659,604 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 10,208 $3.17 6,649,396 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 600 $3.18 6,648,796 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 4,278 $3.19 6,644,518 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 22,475 $3.20 6,622,043 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 23,989 $3.21 6,598,054 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 700 $3.22 6,597,354 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 500 $3.22 6,596,854 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 11,874 $3.22 6,584,980 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 1,600 $3.23 6,583,380 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 15,100 $3.25 6,568,280 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 3,361 $3.26 6,564,919 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 16,900 $3.27 6,548,019 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 700 $3.28 6,547,319 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 200 $3.28 6,547,119 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 100 $3.28 6,547,019 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 24,500 $3.28 6,522,519 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 14,021 $3.29 6,508,498 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 40,357 $3.30 6,468,141 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 4,505 $3.31 6,463,636 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 1,550 $3.31 6,462,086 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 1,700 $3.31 6,460,386 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 5,991 $3.32 6,454,395 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 4,900 $3.33 6,449,495 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 15,406 $3.34 6,434,089 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 500 $3.35 6,433,589 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 23,173 $3.35 6,410,416 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 1,000 $3.36 6,409,416 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2010-04-22 4,200 $3.37 6,405,216 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owners.
  2. Christian Hansen and Florian Sch?nharting are direct investors in a limited partner in the Fund and directors of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Each of Messrs. Hansen and Sch?nharting disclaim beneficial ownership in the securities, except to the extent of their pecuniary interest therein.